Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 1, 1992
Development of prognostic index for primary supratentorial intracerebral tumours
J L Hutton, D F Smith, D Sandemann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1991
The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management
D F Smith, J L Hutton, D Sandemann, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 1, 1995
Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life
A K Wagner, S D Keller, M Kosinski, et al.
Epilepsy Research
|
August 24, 2001
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review
A G Marson, J L Hutton, J P Leach, et al.
Epilepsy Research
|
May 1, 1995
Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial
A Richens, D W Chadwick, J S Duncan, et al.
British Journal of Neurosurgery
|
January 1, 1988
Recurrent aneurysmal subarachnoid haemorrhage: incidence, timing and effects. A re-appraisal in a surgical series
P O'Neill, C R West, D W Chadwick, et al.
British Journal of Neurosurgery
|
January 1, 1988
Post-ictal blood pressure in aneurysmal subarachnoid haemorrhage
P O'Neill, C R West, D W Chadwick, et al.
Molecular Pharmacology
|
February 28, 2003
Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones
D J Naisbitt, M Britschgi, G Wong, et al.
Seizure
|
April 12, 2002
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen
D W Chadwick, T A Betts, H G Boddie, et al.
British Journal of Neurosurgery
|
January 1, 1990
The management of patients with an intrinsic supratentorial brain tumour
D R Sandeman, A P Sandeman, P Buxton, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 1, 1992
Development of prognostic index for primary supratentorial intracerebral tumours
J L Hutton, D F Smith, D Sandemann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1991
The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management
D F Smith, J L Hutton, D Sandemann, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 1, 1995
Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life
A K Wagner, S D Keller, M Kosinski, et al.
Epilepsy Research
|
August 24, 2001
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review
A G Marson, J L Hutton, J P Leach, et al.
Epilepsy Research
|
May 1, 1995
Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial
A Richens, D W Chadwick, J S Duncan, et al.
British Journal of Neurosurgery
|
January 1, 1988
Recurrent aneurysmal subarachnoid haemorrhage: incidence, timing and effects. A re-appraisal in a surgical series
P O'Neill, C R West, D W Chadwick, et al.
British Journal of Neurosurgery
|
January 1, 1988
Post-ictal blood pressure in aneurysmal subarachnoid haemorrhage
P O'Neill, C R West, D W Chadwick, et al.
Molecular Pharmacology
|
February 28, 2003
Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones
D J Naisbitt, M Britschgi, G Wong, et al.
Seizure
|
April 12, 2002
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen
D W Chadwick, T A Betts, H G Boddie, et al.
British Journal of Neurosurgery
|
January 1, 1990
The management of patients with an intrinsic supratentorial brain tumour
D R Sandeman, A P Sandeman, P Buxton, et al.
Page
of 10